Akoya to Participate at Two Upcoming Investor Conferences
Akoya Biosciences (Nasdaq: AKYA), The Spatial Biology Company®, will participate in two investor conferences in August 2022. The first is the UBS Genomics 2.0 and MedTech Innovation Conference, featuring a fireside chat with CEO Brian McKelligon and CBO Niro Ramachandran on August 9th at 1:00 PM PT. The second event, the Canaccord Growth Conference, includes a panel discussion on spatial omics with CEO McKelligon on August 10th at 12:00 PM ET. Both sessions will be broadcast live and available for replay.
- None.
- None.
MARLBOROUGH, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will be participating in two upcoming investor conferences.
- UBS Genomics 2.0 and MedTech Innovation Conference
Fireside Chat – Brian McKelligon, Chief Executive Officer, and Niro Ramachandran, Chief Business Officer, will participate in a fireside chat on Tuesday, August 9th at 1:00 PM PT.
- Canaccord Growth Conference
Panel: The New Frontier of Life Sciences: Spatial Omics is Transforming Biological Analysis – Brian McKelligon, Chief Executive Officer, will participate in a panel discussion on Wednesday, August 10th at 12:00 PM ET. Canaccord Genuity has arranged for all presentations to be broadcasted live and available for replay via the conference portal for 14 days.
About Akoya Biosciences
As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.
Investor Contact:
Priyam Shah
Sr. Director, Investor Relations
Akoya Biosciences, Inc.
investors@akoyabio.com
Media Contact:
Christine Quern
(617) 650-8497
media@akoyabio.com
FAQ
What events is Akoya Biosciences participating in August 2022?
Who will represent Akoya Biosciences at the UBS conference?
What is the focus of the Canaccord Growth Conference panel discussion?
When will the Akoya Biosciences investor presentations be available for replay?
What is Akoya Biosciences known for?
